Flexible risk management in new product development: the case of small- and medium-sized biopharmaceutical enterprises
by Calin Gurau, Ashok Ranchhod
International Journal of Risk Assessment and Management (IJRAM), Vol. 7, No. 4, 2007

Abstract: Risk is a characteristic of innovative industries. The process of new product development in the biopharmaceutical sector is extremely dynamic and unpredictable, creating both risks and opportunities for the small and medium-sized enterprises. The survival and development of these firms is determined by their capacity to develop flexible, but effective responses to the challenges of the competitive environment. This study investigates the risk management procedures implemented by the UK biopharmaceutical SMEs, and the importance of flexibility for enhancing risk management in the new product development process. On the basis of the data collected and interpreted, the study proposes a multi-level model of flexible risk management approach for biopharmaceutical firms.

Online publication date: Sun, 11-Mar-2007

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Risk Assessment and Management (IJRAM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com